News from inspiremd, inc

Jul 08, 2014, 08:30 ET

InspireMD Announces Successful Completion of CGuard™ CARENET (CARotid Embolic protection study using microNET) Trial

InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced that it has...

Jul 01, 2014, 08:30 ET

InspireMD Selected for Inclusion in the Russell Microcap® Index

 InspireMD Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems, today announced that it has been...

Jun 23, 2014, 08:30 ET

InspireMD Receives European Regulatory Approval to Resume Manufacturing and Distribution of MGuard(TM) Prime EPS

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems (EPS), today announced that it...

Jun 18, 2014, 08:30 ET

InspireMD to Present at the 9th Annual JMP Securities Healthcare Conference

InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), today announced that its CEO, Alan Milinazzo, will be presenting at the 9th Annual...

May 20, 2014, 08:30 ET

InspireMD to Showcase Embolic Systems with MicroNet™ Technology and Results from MASTER I Trial at EuroPCR Conference

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems, today announced that it will be...

May 09, 2014, 09:00 ET

InspireMD to Present at the Bank of America Merrill Lynch 2014 Health Care Conference

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), today announced that its CEO, Alan Milinazzo, will be presenting at the Bank...

May 07, 2014, 17:49 ET

InspireMD Reports Financial Results for the First Quarter Ended March 31, 2014

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced financial and...

May 07, 2014, 16:05 ET

InspireMD Announces Positive Results from iMOS Prime Registry for the MGuard Prime EPS

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection stents (EPS), today announced new results from...

Apr 30, 2014, 16:30 ET

InspireMD to Report Financial Results for Quarter Ended March 31, 2014 on Wednesday, May 7th

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection stents, announced today that it will release...

Apr 30, 2014, 10:31 ET

InspireMD Announces Voluntary Field Action for MGuard™ Prime EPS

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems (EPS), today announced that it...

Mar 19, 2014, 09:00 ET

InspireMD Announces First Patient Enrolled Into New CGuard(TM) CARENET (CARotid Embolic protection study using microNET) Clinical Trial

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems, today announced that it...

Mar 06, 2014, 08:30 ET

InspireMD to Present at the 26th Annual ROTH Conference

InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), today announced that its CEO, Alan Milinazzo, will be presenting at the 26th...

Feb 27, 2014, 08:30 ET

InspireMD to Present at the Cowen & Company 34th Annual Health Care Conference

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), today announced that its CEO, Alan Milinazzo, will be presenting at...

Feb 26, 2014, 16:05 ET

InspireMD Reports Financial Results for the Quarter and Six Month Period Ended December 31, 2013

 InspireMD Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems, today announced financial and...

Feb 18, 2014, 08:30 ET

InspireMD to Report Financial Results for Six Month Period Ended December 31, 2013 on Wednesday, February 26, 2014

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection stents, announced today that it will release...

Feb 05, 2014, 09:23 ET

InspireMD Reports Successful Implantation of the New CGuard™ Carotid Embolic System with MicroNet™ Technology

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems, today announced that its new...

Dec 03, 2013, 08:30 ET

InspireMD to Present at the 24th Annual Oppenheimer & Co. Healthcare Conference in New York City on December 11th

InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), today announced that its CEO, Alan Milinazzo will be presenting at the 24th Annual...

Dec 02, 2013, 08:30 ET

InspireMD Appoints Rick Olson as Vice President of Global Sales Operations

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems, today announced the appointment of...

Nov 19, 2013, 09:13 ET

InspireMD Announces Upcoming Investor Event in Israel

InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection stents, today announced that it will host an...

Nov 11, 2013, 16:01 ET

InspireMD Reports Financial Results for Quarter Ended September 30, 2013

 InspireMD Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection stents, today announced financial results...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer